Randomized, double-blind, split-side, comparison study of moisturizer containing MAS064D and 1% hydrocortisone in the treatment of infantile seborrheic dermatitis
Phase 4
Completed
- Conditions
- children less than 1 year oldseborrheic dermatitisMAS064Dƹ% hydrocortisone,efficacy,seborrheic dermatitis
- Registration Number
- TCTR20160819001
- Lead Sponsor
- A.Menarini (Thailand) Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
children, less than 1 year old, with seborrheic dermatitis who did not receive any treatment within 2 weeks
Exclusion Criteria
children with infection
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical improvement 28 days Scoring system
- Secondary Outcome Measures
Name Time Method flare free period 28 days scoring system,safety of products 28 days clinical evaluation